Gemfibrozil
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
65862-624 -
Package NDC
65862-624-05 -
Package NDC
65862-624-60 -
Application number
ANDA202726 -
SPL ID
9dfb61ff-d04d-4c5f-85e6-c9dfae7c395e -
SPL set ID
a68f430e-7c98-4bd9-8902-758706713996 -
UNII
Q8X02027X3 -
RxCUI
310459
What the source publishes
- Labeler
- Aurobindo Pharma Limited
- Active ingredients
- Gemfibrozil
- Form
- TABLET, FILM COATED
- Routes
- ORAL
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Gemfibrozil",
"splId": "9dfb61ff-d04d-4c5f-85e6-c9dfae7c395e",
"labels": [
{
"setId": "a68f430e-7c98-4bd9-8902-758706713996",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=a68f430e-7c98-4bd9-8902-758706713996",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=a68f430e-7c98-4bd9-8902-758706713996"
}
],
"routes": [
"ORAL"
],
"labeler": "Aurobindo Pharma Limited",
"finished": true,
"packaging": [
{
"sample": false,
"description": "500 TABLET, FILM COATED in 1 BOTTLE (65862-624-05)",
"package_ndc": "65862-624-05",
"identifierStatus": "well-formed",
"marketing_start_date": "20150916"
},
{
"sample": false,
"description": "60 TABLET, FILM COATED in 1 BOTTLE (65862-624-60)",
"package_ndc": "65862-624-60",
"identifierStatus": "well-formed",
"marketing_start_date": "20150916"
}
],
"productId": "65862-624_9dfb61ff-d04d-4c5f-85e6-c9dfae7c395e",
"useDomain": "unknown",
"dosageForm": "TABLET, FILM COATED",
"productNdc": "65862-624",
"deaSchedule": null,
"genericName": "Gemfibrozil",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "GEMFIBROZIL",
"strength": "600 mg/1"
}
],
"applicationNumber": "ANDA202726",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20150916",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175596",
"N0000175375",
"M0543661"
],
"unii": [
"Q8X02027X3"
],
"rxcui": [
"310459"
],
"spl_set_id": [
"a68f430e-7c98-4bd9-8902-758706713996"
],
"pharm_class_cs": [
"Fibric Acids [CS]"
],
"pharm_class_epc": [
"Peroxisome Proliferator Receptor alpha Agonist [EPC]"
],
"pharm_class_moa": [
"Peroxisome Proliferator-activated Receptor alpha Agonists [MoA]"
],
"manufacturer_name": [
"Aurobindo Pharma Limited"
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:65862-624_9dfb61ff-d04d-4c5f-85e6-c9dfae7c395e"